FdaApplication
ANDA 219319
Identifiers
- fda_app_no: ANDA219319
Properties
| Property | Value |
|---|---|
| applicant_name | SENORES PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2025-08-07 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GABAPENTIN | GABAPENTIN | 400MG | CAPSULE;ORAL |
| GABAPENTIN | GABAPENTIN | 100MG | CAPSULE;ORAL |
| GABAPENTIN | GABAPENTIN | 300MG | CAPSULE;ORAL |
| GABAPENTIN | GABAPENTIN | 200MG | CAPSULE;ORAL |
4 products